高瀾股份(300499.SZ):已向國內外數十條特高壓直流輸電項目提供水冷產品
格隆匯5月14日丨高瀾股份(300499.SZ)近日在接待機構投資者調研時表示,在直流水冷領域,公司已向國內外數十條特高壓直流輸電項目提供水冷產品。公司在該領域中擁有豐富的技術積累及廣泛的客户資源,與國內外多家優質客户有着穩定的合作關係,擁有較高的市場佔有率。同時,公司在該領域擁有大量的發明專利及軟件著作權,填補了國內特高壓領域的技術空白,起草或修訂多項國家標準、行業標準、團體標準。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.